Woo, Jessica G.
Melchior, John T.
Swertfeger, Debi K.
Remaley, Alan T.
Sise, Ebrima A.
Sosseh, Fatou
Welge, Jeffrey A.
Prentice, Andrew M.
Davidson, W. Sean
Moore, Sophie E.
Woollett, Laura A.
Funding for this research was provided by:
National Institutes of Health (HL158100, HL128203)
Bill and Melinda Gates Foundation (OPP1110668)
Article History
Received: 15 December 2022
Accepted: 16 January 2023
First Online: 3 February 2023
Declarations
:
: The ENID trial and this sub-study were approved by the joint Gambian Government/Medical Research Council (MRC) Unit and additional approval was obtained from the Institutional Review Board at the University of Cincinnati as described [].
: There are no competing interests with any of the authors.